Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Aakaar Medical Technologies IPO
Price Band
₹68.0–72.0
Issue Size
₹27.0 Cr
Lot Size
1,600 shares
Min Investment
₹115,200
GMP
—
Issue Price
₹72.0
Aakaar Medical Technologies IPO AI Summary
- Aakaar Medical Technologies IPO is listed on NSE SME in the Personal Care sector.
- Price band: ₹68.0–₹72.0 per share, lot size 1,600 shares (min. investment ₹115,200).
- Subscription window: 20 Jun–24 Jun 2025, listing on 27 Jun 2025.
Aakaar Medical Technologies Limited is set to launch its IPO with a price band of ₹68.0 to ₹72.0, aiming to raise ₹27.0 Cr. The company has shown consistent revenue and profit growth over the past three fiscal years, supported by a diverse product portfolio and a strong management team.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Aakaar Medical Technologies IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 24 Jun 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Aakaar Medical Technologies IPO Grey Market Premium (GMP) Today
GMP not available yet
Grey Market Premium is updated daily. Check back closer to the listing date.
About the Company
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices. The company deals in speciality products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, Cosmetologists. The company's product portfolio encompasses both own brands, which consist of domestically manufactured products and internationally produced devices, and imported brands sourced from countries such as South Korea, Spain, Italy, and Austria. The company supplies products and devices mainly to dermatologists, plastic surgeons, and aesthetic physicians, who sell them to end consumers and use some consumables in treatments. The company's product range includes the following:- Homecare and professional skin care Injectable and contouring, Homecare for skin, Professional Hair Care Injectable and contouring, Homecare for skin Professional Skincare products Hair Growth Serum & Tablets Hair Serum, Anti hair loss solution, Tablet Medifacial Kit Device for urinary incontinence Tattoo removal, pigmentation and skin rejuvenation devices Laser Hair Reduction devices Hair Transplant Device The company has branches across India with a team of 90 trained sales and service engineers, serving thousands of satisfied customers. The company sells its products to the states of Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu. Competitive Strength Experienced Management & Leadership Team Diversified Customer Base Diversified Product Base Pan India reach through our Consignment Sales partner.
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 51.85 | 34.01 | 23.23 |
| Total Income | 61.76 | 46.27 | 32.88 |
| Profit After Tax | 6.04 | 2.87 | 2.15 |
| EBITDA | 9.74 | 5.00 | 3.53 |
| NET Worth | 23.20 | 12.53 | 9.66 |
| Reserves and Surplus | 12.78 | 11.84 | 8.96 |
| Total Borrowing | 22.74 | 15.06 | 5.87 |
Key Ratios
EPS
₹5.79
NAV
₹22.26
ROCE
21.02%
RoNW
33.81%
P/B Value
5.23
P/E Ratio
12.43
Market Cap
₹102.04 Cr
PAT Margin
9.81%
Debt/Equity
0.98
Promoters
Dilip Ramesh Meswani and Bindi Dilip Meswani
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding working capital requirements of the Company 20.35 2 General Corporate Purposes 3.29 3 Issue Expenses 3.36 Total 27.00
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹32.88 Cr in the period ending 31 Mar 2023, rising to ₹46.27 Cr by 31 Mar 2024, and further increasing to ₹61.76 Cr by 31 Mar 2025. This shows a consistent growth in revenue over the three periods.
Profit Trend
Profit After Tax was ₹2.15 Cr in the period ending 31 Mar 2023, increasing to ₹2.87 Cr by 31 Mar 2024, and reaching ₹6.04 Cr by 31 Mar 2025. This indicates a significant rise in profitability over the periods.
Grey Market Premium, Explained
The grey market refers to the unofficial trading of shares before they are listed on the stock exchange. Grey market premium (GMP) is an indicator of the expected listing price of an IPO. It reflects the demand and supply dynamics in the grey market and can provide insights into potential listing gains or losses.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their individual risk tolerance and investment goals. It's important to consider the company's fundamentals and market conditions before making any decisions.
Who May Want to Wait
Investors who are risk-averse or those who prefer stable, established companies may want to avoid this IPO, as it operates in a niche market and may experience volatility.
IPO Timeline, Explained
The IPO opens for subscription on 20 June 2025 and closes on 24 June 2025. Allotment of shares will be done on 25 June 2025, with the listing date set for 27 June 2025.
Listing Gains — The Risk
Listing day gains are not guaranteed and can be influenced by various factors including market conditions, investor sentiment, and the company's performance. It is essential to understand that while some IPOs may experience significant gains on listing day, others may not perform as well.
This evaluation is generated from Aakaar Medical Technologies's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is the price band of Aakaar Medical Technologies IPO?
The price band of Aakaar Medical Technologies IPO is ₹68.0–₹72.0 per share.
When does Aakaar Medical Technologies IPO open and close?
Aakaar Medical Technologies IPO opens on 20 June 2025 and closes on 24 June 2025.
When does Aakaar Medical Technologies IPO list on the stock exchange?
Aakaar Medical Technologies IPO listed on 27 June 2025 at ₹72.0.
What is the lot size for Aakaar Medical Technologies IPO?
The lot size for Aakaar Medical Technologies IPO is 1600 shares, requiring a minimum investment of ₹115,200.
What is the price band for the IPO?
The price band for the IPO is ₹68.0 to ₹72.0.
What is the minimum investment required?
The minimum investment required is ₹115,200.
What is the lot size for this IPO?
The lot size for this IPO is 1,600 shares.
When is the listing date?
The listing date is set for 27 June 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected premium or discount at which the shares may trade on their listing day.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
20 Jun 2025
Close
24 Jun 2025
Allotment
25 Jun 2025
Listing
27 Jun 2025
Similar IPOs in Personal Care
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Aakaar Medical Technologies?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.